NCT02125812

Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis

Adjunctive Systemic Administration of Moxifloxacin in the Treatment of Aggressive Periodontitis: Double-blind Controlled Clinical Trial

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Facultad Nacional de Salud Publica · Academic / Other
• Sex: All
• Age: 15 Years – 30 Years
• Healthy volunteers: Accepted

Summary

The adjunctive use of systemically administered antibiotics has been shown to provide a better clinical outcome, particularly in terms of probing depth (PD) reduction and attachment-level gain than SRP in subjects with Aggressive Periodontitis. The overall objective of this study is to evaluate the clinical and microbiological efficacy of moxifloxacin as an adjunct to scaling and root planing versus scaling and root planing over placebo in the treatment of aggressive periodontitis.

Conditions

• Aggressive Periodontitis

Interventions

Type	Name	Description
OTHER	scaling and systemic moxifloxacin	scaling and root planing (SRP) combined with systemic moxifloxacin
OTHER	scaling and root planing	scaling and root planing

Timeline

• Start date: 2011-08-01
• Primary completion: 2014-03-01
• Completion: 2014-04-01
• First posted: 2014-04-29
• Last updated: 2014-06-02

Locations

1 site across 1 country: Colombia